2023 annual financial data
Estrella Immunopharma 2023 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -7.31M USD and net income was -7.31M USD.
Operating cash flow was -16.07M USD.
Get free Estrella Immunopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -7.31M USD
- Net income
- -7.31M USD
- Operating cash flow
- -16.07M USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Estrella Immunopharma financial years